(Reuters) – The U.S. CDC on Friday backed a booster shot of the Pfizer/BioNTech COVID-19 vaccine for Americans aged 65 and older, adults with underlying medical conditions and those in high-risk working and institutional settings despite calls for a narrower scope by a panel of expert advisers that would exclude the latter group. Read full story